- Home
- ABCL vs CRON Comparison
ABCL vs CRON Comparison
Compare ABCL & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABCL
- CRON
- Stock Information
- Founded
- ABCL 2012
- CRON 2012
- Country
- ABCL Canada
- CRON Canada
- Employees
- ABCL N/A
- CRON N/A
- Industry
- ABCL Biotechnology: Pharmaceutical Preparations
- CRON Medicinal Chemicals and Botanical Products
- Sector
- ABCL Health Care
- CRON Health Care
- Exchange
- ABCL Nasdaq
- CRON Nasdaq
- Market Cap
- ABCL 895.0M
- CRON 795.2M
- IPO Year
- ABCL 2020
- CRON N/A
- Fundamental
- Price
- ABCL $2.68
- CRON $1.90
- Analyst Decision
- ABCL Buy
- CRON Hold
- Analyst Count
- ABCL 3
- CRON 2
- Target Price
- ABCL $8.50
- CRON $3.00
- AVG Volume (30 Days)
- ABCL 2.4M
- CRON 1.0M
- Earning Date
- ABCL 11-04-2024
- CRON 11-12-2024
- Dividend Yield
- ABCL N/A
- CRON N/A
- EPS Growth
- ABCL N/A
- CRON N/A
- EPS
- ABCL N/A
- CRON N/A
- Revenue
- ABCL $32,962,000.00
- CRON $111,229,000.00
- Revenue This Year
- ABCL N/A
- CRON $35.84
- Revenue Next Year
- ABCL $36.56
- CRON $15.66
- P/E Ratio
- ABCL N/A
- CRON N/A
- Revenue Growth
- ABCL N/A
- CRON 30.31
- 52 Week Low
- ABCL $2.34
- CRON $1.86
- 52 Week High
- ABCL $6.06
- CRON $3.14
- Technical
- Relative Strength Index (RSI)
- ABCL 44.26
- CRON 43.81
- Support Level
- ABCL $2.76
- CRON $1.90
- Resistance Level
- ABCL $3.05
- CRON $2.00
- Average True Range (ATR)
- ABCL 0.16
- CRON 0.06
- MACD
- ABCL -0.03
- CRON -0.00
- Stochastic Oscillator
- ABCL 0.00
- CRON 34.78
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
About CRON Cronos Group Inc. Common Share
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.